Effect of AMPA receptor modulators on hippocampal and cortical function

European Journal of Pharmacology

Volumn 394, Issue 1, 2000, Pages 85-90

  Black, Mark D ^a   Wotanis, Jill ^a   Schilp, Donald E ^a   Hanak, Susan E ^a   Sorensen, Stephen M ^a   Wettstein, Joseph G ^a  

^a SANOFI   (France)

Author keywords

AMPA ( amino 3 hydroxy 5 methyl 4 isoxazole proprionic acid); AMPA receptor modulator; Cortex; Hippocampus

Indexed keywords

1 (1,3 BENZODIOXOL 5 YLCARBONYL) PIPERIDINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR AGONIST; ANIRACETAM; CYCLOTHIAZIDE; GLUTAMATE RECEPTOR; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG RECEPTOR BINDING; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MALE; MEMBRANE DEPOLARIZATION; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CEREBRAL CORTEX; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HIPPOCAMPUS; MALE; PIPERIDINES; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA;

EID: 0034616203     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00120-5     Document Type: Article

References (32)

1. Bigge C.F., Nikam S.S. AMPA receptor agonists, antagonists and modulators - their potential for clinical utility. Expert Opin. Ther. Pat. 7(10):1997;1099-1114.
2. Boulter J., Hollmann M., O'Shea-Greenfield A., Hartley M., Deneris E., Maron C., Heinemann S. Molecular cloning and functional expression of glutamate receptor subunit genes. Science. 249(4972):1990;1033-1037.
3. Boxall A.R., Garthwaite J. Synaptic excitation mediated by AMPA receptors in rat cerebellar slices is selectively enhanced by aniracetam and cyclothiazide. Neurochem. Res. 20(5):1995;605-609.
4. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 8(1):1992;189-198.
5. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1(8):1988;623-634.
6. Fletcher E.J., Lodge D. New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors. Pharmacol. Ther. 70(1):1996;65-89.
7. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron. 15(1):1995;193-204.
8. Harrison N.L., Simmonds M.A. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br. J. Pharmacol. 84(2):1985;381-391.
9. Hennegriff M., Arai A., Kessler M., Vanderklish P., Mutneja M.S., Rogers G., Neve R.L., Lynch G. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators. J. Neurochem. 68(6):1997;2424-2434.
10. Hollmann M., O'Shea-Greenfield A., Rogers S.W., Heinemann S. Cloning by functional expression of a member of the glutamate receptor family. Nature. 342(6250):1989;643-648.
11. Hume R.I., Dingledine R., Heinemann S.F. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science. 253(5023):1991;1028-1031.
12. Ingvar M., Ambros-Ingerson J., Davis M., Granger R., Kessler M., Rogers G.A., Schehr R.S., Lynch G. Enhancement by an ampakine of memory encoding in humans. Exp. Neurol. 146(2):1997;553-559.
13. Johansen T.H., Chaudhary A., Verdoorn T.A. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol. Pharmacol. 48(5):1995;946-955.
14. Keinanen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A., Sakmann B., Seeburg P.H. A family of AMPA-selective glutamate receptors. Science. 249(4968):1990;556-560.
15. Kessler M., Mutneja M.S., Rogers G., Lynch G. Regional preferences of AMPA receptor modulators determined through agonist binding autoradiography. Brain Res. 783(1):1998;121-126.
16. Larson J., Le T., Hall R.A., Lynch G. Effects of cyclothiazide on synaptic responses in slices of adult and neonate rat hippocampus. NeuroReport. 5:1994;389-392.
17. Lee C.R., Benfield P. Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders. Drugs and Aging. 4(3):1994;257-273.
18. Lomeli H., Mosbacher J., Melcher T., Hoger T., Geiger J.R., Kuner T., Monyer H., Higuchi M., Bach A., Seeburg P.H. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science. 266(5191):1994;1709-1713.
19. Lynch G., Granger R., Ambros-Ingerson J., Davis C.M., Kessler M., Schehr R. Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans. Exp. Neurol. 145(1):1997;89-92.
20. Lynch G., Kessler M., Rogers G., Ambros-Ingerson J., Granger R., Schehr R.S. Psychological effects of a drug that facilitates brain AMPA receptors. Int. Clin. Psychopharmacol. 11(1):1996;13-19.
21. Malenka R.C. The role of postsynaptic calcium in the induction of long-term potentiation. Mol. Neurobiol. 5(2-4):1991;289-295.
22. Martin D., Bowe M.A., Nadler J.V. A grease-gap method for studying the excitatory amino acid pharmacology of CA1 hippocampal pyramidal cells. J. Neurosci. Methods. 29(2):1989;107-114.
23. Monyer H., Seeburg P.H., Wisden W. Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing. Neuron. 6(5):1991;799-810.
24. Partin K.M., Patneau D.K., Mayer M.L. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol. Pharmacol. 46(1):1994;129-138.
25. Schilp D.E., Sorensen S.M., Wettstein J.G., Black M.D. Effect of glycine antagonists on an in vitro model of stroke. Drug Dev. Res. 46:1999;134-138.
26. Sommer B., Keinanen K., Verdoorn T.A., Wisden W., Burnashev N., Herb A., Kohler M., Takagi T., Sakmann B., Seeburg P.H. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science. 249(4976):1990;1580-1585.
27. Sommer B., Seeburg P.H. Glutamate receptor channels: novel properties and new clones. Trends Pharmacol. Sci. 13(7):1992;291-296.
28. Stein E., Cox J.A., Seeburg P.H., Verdoorn T.A. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes. Mol. Pharmacol. 42(5):1992;864-871.
29. Teyler T.J., Cavus I., Coussens C., DiScenna P., Grover L., Lee Y.P., Little Z. Multideterminant role of calcium in hippocampal synaptic plasticity. Hippocampus. 4(6):1994;623-634.
30. Vanover K.E. Effects of AMPA receptor positive modulators on amphetamine-and dizocilpine-induced locomotion. Eur. J. Pharmacol. 332(2):1997;115-119.
31. Wisden W., Seeburg P.H. Mammalian ionotropic glutamate receptors. Curr. Opin. Neurobiol. 3(3):1993;291-298.
32. Yamada K. Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease? Neurobiol. Dis. 5:1998;67-80.